SMTL ID : 4r5s.1

Crystal structure of EGFR 696-1022 L858R in complex with FIIN-3

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

monomer

Ligands

1 x FI3: N-[4-({[(2,6-dichloro-3,5-dimethoxyphenyl)carbamoyl](6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)amino}methyl)phenyl]propanamide(Covalent)

FI3.1: 17 residues within 4Å: Chain A: L.27, V.35, A.52, K.54, E.71, M.75, L.97, T.99, Q.100, L.101, M.102, P.103, G.105, C.106, D.109, T.163, D.164 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.27 Hydrogen bonds: A:T.99, A:M.102, A:M.102, A:D.164 Water bridges: A:N.151

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tan, L. et al., Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors. Proc.Natl.Acad.Sci.USA (2014)

Release Date

2014-11-12

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence